1. Home
  2. INO vs SER Comparison

INO vs SER Comparison

Compare INO & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INO
  • SER
  • Stock Information
  • Founded
  • INO 1979
  • SER 2017
  • Country
  • INO United States
  • SER United States
  • Employees
  • INO N/A
  • SER N/A
  • Industry
  • INO Medical/Dental Instruments
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • INO Health Care
  • SER Health Care
  • Exchange
  • INO Nasdaq
  • SER Nasdaq
  • Market Cap
  • INO 69.3M
  • SER 56.5M
  • IPO Year
  • INO 1998
  • SER 2018
  • Fundamental
  • Price
  • INO $1.43
  • SER $5.97
  • Analyst Decision
  • INO Buy
  • SER Strong Buy
  • Analyst Count
  • INO 5
  • SER 2
  • Target Price
  • INO $8.80
  • SER $13.00
  • AVG Volume (30 Days)
  • INO 3.4M
  • SER 31.0K
  • Earning Date
  • INO 08-07-2025
  • SER 08-08-2025
  • Dividend Yield
  • INO N/A
  • SER N/A
  • EPS Growth
  • INO N/A
  • SER N/A
  • EPS
  • INO N/A
  • SER N/A
  • Revenue
  • INO $283,099.00
  • SER $51,000.00
  • Revenue This Year
  • INO N/A
  • SER N/A
  • Revenue Next Year
  • INO $20,588.06
  • SER N/A
  • P/E Ratio
  • INO N/A
  • SER N/A
  • Revenue Growth
  • INO N/A
  • SER N/A
  • 52 Week Low
  • INO $1.30
  • SER $3.81
  • 52 Week High
  • INO $11.44
  • SER $11.57
  • Technical
  • Relative Strength Index (RSI)
  • INO 40.29
  • SER 57.60
  • Support Level
  • INO $1.46
  • SER $5.11
  • Resistance Level
  • INO $1.56
  • SER $5.67
  • Average True Range (ATR)
  • INO 0.08
  • SER 0.38
  • MACD
  • INO 0.02
  • SER 0.05
  • Stochastic Oscillator
  • INO 43.33
  • SER 66.22

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: